Masatoshi HAGIWARA,Masayasu TOYOMOTO,Takamitsu HOSOYA,Suguru YOSHIDA
申请号：
US16346032
公开号：
US20200188382A1
申请日:
2017.10.31
申请国别(地区):
US
年份:
2020
代理人:
摘要：
A method for inducing programmed cell death in cancer cells and a pharmaceutical composition therefor are provided.Provided is a method for inducing programmed cell death in cancer cells, the method including enhancing production of nitric oxide in cancer cells. Provided is a pharmaceutical composition for inducing programmed cell death in cancer cells, the pharmaceutical composition containing, as an active component, a compound that enhances production of nitric oxide in cancer cells. Provided is use of a compound that enhances production of nitric oxide in cancer cells, in a method for preventing, improving, suppressing progression of, and/or treating cancers.
